Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedJun 07, 2026
DataAggregated Company Financials
Companies204
  • 7D-1.2%
  • 3M2.7%
  • 1Y6.6%
  • YTD1.3%

Over the last 7 days, the market has dropped 1.2%, driven by a decline of 2.8% in the Consumer Staples sector. As for the longer term, the market has actually risen by 6.6% in the last year. Earnings are forecast to grow by 11% annually.

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 07 Jun 2026CHF 2.0tCHF 776.7bCHF 104.2b20.3x19.1x2.6x
Tue, 05 May 2026CHF 2.0tCHF 773.6bCHF 103.2b20.5x19x2.5x
Thu, 02 Apr 2026CHF 1.9tCHF 781.8bCHF 109.8b20.4x17.7x2.5x
Sat, 28 Feb 2026CHF 2.1tCHF 788.2bCHF 116.4b21x17.8x2.6x
Mon, 26 Jan 2026CHF 2.0tCHF 793.2bCHF 114.3b20.6x17.5x2.5x
Wed, 24 Dec 2025CHF 2.0tCHF 796.2bCHF 114.1b20.2x17.4x2.5x
Fri, 21 Nov 2025CHF 1.9tCHF 806.8bCHF 115.2b19.3x16.5x2.3x
Sun, 19 Oct 2025CHF 1.9tCHF 773.4bCHF 90.3b19.2x21.1x2.5x
Tue, 16 Sep 2025CHF 1.9tCHF 773.6bCHF 90.0b19.9x20.6x2.4x
Thu, 14 Aug 2025CHF 1.8tCHF 776.7bCHF 90.0b21.1x20.4x2.4x
Sat, 12 Jul 2025CHF 1.8tCHF 784.5bCHF 106.7b20.4x17.2x2.3x
Mon, 09 Jun 2025CHF 1.8tCHF 785.0bCHF 106.4b20.3x17.4x2.4x
Wed, 07 May 2025CHF 1.8tCHF 783.6bCHF 105.9b19.8x17.1x2.3x
Fri, 04 Apr 2025CHF 1.8tCHF 843.2bCHF 158.2b18.8x11.3x2.1x
Sun, 02 Mar 2025CHF 1.9tCHF 811.8bCHF 117.7b20.6x16.3x2.4x
Tue, 28 Jan 2025CHF 1.8tCHF 816.3bCHF 117.6b21.6x15.6x2.3x
Thu, 26 Dec 2024CHF 1.7tCHF 815.4bCHF 117.5b20.7x14.6x2.1x
Sat, 23 Nov 2024CHF 1.7tCHF 813.2bCHF 117.3b19.9x14.9x2.1x
Mon, 21 Oct 2024CHF 1.8tCHF 806.2bCHF 114.4b21.3x16.1x2.3x
Wed, 18 Sep 2024CHF 1.8tCHF 802.0bCHF 113.9b20.9x15.8x2.2x
Fri, 16 Aug 2024CHF 1.8tCHF 808.0bCHF 114.1b21.7x16x2.3x
Sun, 14 Jul 2024CHF 1.9tCHF 801.1bCHF 125.5b21.8x14.7x2.3x
Tue, 11 Jun 2024CHF 1.8tCHF 801.1bCHF 125.7b22.1x14.6x2.3x
Thu, 09 May 2024CHF 1.8tCHF 802.3bCHF 126.0b21.4x13.9x2.2x
Sat, 06 Apr 2024CHF 1.8tCHF 766.9bCHF 97.0b21.3x18.1x2.3x
Mon, 04 Mar 2024CHF 1.7tCHF 785.2bCHF 111.0b20.2x15.5x2.2x
Wed, 31 Jan 2024CHF 1.7tCHF 764.3bCHF 109.6b17.8x15.6x2.2x
Fri, 29 Dec 2023CHF 1.7tCHF 758.4bCHF 108.9b18.3x15.4x2.2x
Sun, 26 Nov 2023CHF 1.6tCHF 771.5bCHF 111.2b18x14.7x2.1x
Tue, 24 Oct 2023CHF 1.6tCHF 759.7bCHF 100.3b17.7x15.5x2.1x
Thu, 21 Sep 2023CHF 1.7tCHF 751.3bCHF 99.4b18.6x16.9x2.2x
Sat, 19 Aug 2023CHF 1.6tCHF 747.4bCHF 75.2b18x21.8x2.2x
Mon, 17 Jul 2023CHF 1.7tCHF 749.7bCHF 76.3b19.4x22.4x2.3x
Wed, 14 Jun 2023CHF 1.7tCHF 759.6bCHF 77.2b19.6x22.5x2.3x
Price to Earnings Ratio

22.5x


Total Market Cap: CHF 1.7tTotal Earnings: CHF 77.2bTotal Revenue: CHF 759.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 16.8x202420252026
Current Market PE
  • Investors are optimistic on the Swiss market, and appear confident in strong long term growth rates.
  • The market is trading at a PE ratio of 19.1x which is higher than its 3-year average PE of 16.8x.
Past Earnings Growth
  • The earnings for Swiss listed companies have grown 11% per year over the last three years, while revenues have remained steady.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market-1.19%
Industrials0.052%
Financials-0.67%
Healthcare-0.74%
Utilities-1.36%
Materials-2.04%
Tech-2.29%
Consumer Staples-2.81%
Consumer Discretionary-2.95%
Telecom-3.02%
Real Estate-3.07%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading above its 3-year average PE ratio of 28.3x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 19.7% which is higher than its past year's earnings decline of 14.4% per year.
  • The Financials sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 7.1x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings decline of 14% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 7.0% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
UBSG UBS GroupCHF 37.631.6%
+CHF 1.8b		35.0%PE15.8xFinancials
KNIN Kuehne + Nagel InternationalCHF 191.856.4%
+CHF 1.4b		2.3%PE27.3xIndustrials
BEAN BELIMO HoldingCHF 902.509.1%
+CHF 928.6m		12.8%PE61.1xIndustrials
ALC AlconCHF 53.122.0%
+CHF 497.5m		-26.2%PE39.7xHealthcare
BAER Julius Bär GruppeCHF 65.722.7%
+CHF 348.5m		24.6%PE17.6xFinancials
See more

Market Insights

Header cover image
The most anticipated IPO in history lands next week at an expected $1.75 trillion price tag. Part launch business, part Starlink, and increasingly an AI bet — could the SpaceX IPO be carrying a valuation that has no room for error?
Continue reading
Land of the rising yields 📈

Latest News

NOVN
CHF 117.98
Novartis
7D
0.1%
1Y
21.5%
Narrative Update • Jun 06

NOVN: Broad Pipeline Data And Manufacturing Investments Will Support Balanced Outlook

Analysts have nudged their price target for Novartis higher from CHF 122.04 to CHF 123.55, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E that collectively point to a slightly stronger long term outlook for the stock. What's in the News Pluvicto plus standard of care in PSMA positive metastatic hormone sensitive prostate cancer showed consistent radiographic progression free survival benefits across disease volume and presentation subgroups, along with supportive safety data, at ASCO 2026 and in the Phase 1 AcTION trial for actinium based RLT, reinforcing Novartis' radioligand therapy focus (source: Novartis, ASCO 2026).
NESN
CHF 76.96
Nestlé
7D
-3.1%
1Y
-11.2%
Narrative Update • Jun 06

NESN: Ready To Drink Expansion And Ice Cream Review Will Support 2026 Execution

Nestlé's analyst price target has been adjusted slightly higher by CHF 2, with analysts pointing to modest tweaks in revenue growth expectations and valuation assumptions as the key drivers of the change. Analyst Commentary Recent Street research on Nestlé has focused on fine tuning price targets and reassessing valuation as new information filters through, rather than making sweeping calls on the stock.
HOLN
CHF 74.44
Holcim
7D
-3.8%
1Y
-21.3%
Narrative Update • Jun 05

HOLN: Cement Margins And Electrification Projects Will Shape Measured Future Upside

Holcim's analyst price target has been raised by CHF 2 to reflect slightly higher fair value estimates and improved margin expectations, supported by a series of recent upgrades and renewed coverage from major banks. Analyst Commentary Bullish Takeaways Bullish analysts see the higher price target as consistent with their view that Holcim's earnings power can support a slightly richer valuation multiple, provided current margin expectations are met.
ZURN
CHF 550.20
Zurich Insurance Group
7D
-1.2%
1Y
-5.3%
Narrative Update • Jun 05

ZURN: Future Returns Will Reflect Beazley Integration And Persistent Cyclical Pricing Pressures

Analysts have modestly raised the fair value estimate for Zurich Insurance Group, with the updated price target moving from CHF 574.68 to CHF 580.51 as they factor in slightly higher projected revenue growth, stable margins and neutral ratings that acknowledge both new growth opportunities and ongoing pricing pressures. Analyst Commentary Recent research coverage has coalesced around neutral ratings, with analysts broadly agreeing that Zurich Insurance Group offers a balanced mix of growth opportunities and execution risks.
UBSG
CHF 37.63
UBS Group
7D
1.6%
1Y
35.0%
PGHN
CHF 710.80
Partners Group Holding
7D
-14.1%
1Y
-34.2%
ROP
CHF 327.10
Roche Holding
7D
-0.7%
1Y
22.0%
ALC
CHF 53.12
Alcon
7D
2.0%
1Y
-26.2%
Narrative Update • Jun 04

ALC: Share Buybacks And Patent Royalties Will Shape Measured Forward Outlook

Analysts have adjusted their price target on Alcon to reflect updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, resulting in a revised target of CHF 56.34 compared with the previous CHF 60.81. What's in the News Alcon announced a share repurchase program of up to US$1,500 million, funded by cash generated from operations, with repurchased shares to be cancelled as a return of capital to shareholders; the program is valid for 3 years.
GALD
CHF 161.50
Galderma Group
7D
-3.0%
1Y
39.3%
Narrative Update • Jun 03

GALD: Rising Optimism Will Meet Acne Franchise Concentration Risk

Analysts have lifted the Galderma Group price target by about CHF 1 to roughly CHF 183.50, reflecting updated views on fair value, slightly adjusted revenue growth and profit margin assumptions, and continued supportive research commentary across several firms. Analyst Commentary Recent research has focused on how Galderma can execute on its growth plans while justifying higher valuation ranges, with several firms adjusting price targets and ratings in quick succession.
BAER
CHF 65.72
Julius Bär Gruppe
7D
2.7%
1Y
24.6%
Narrative Update • Jun 02

BAER: Future Returns Will Hinge On Execution As Profit Signals Improve

Analysts nudged the fair value estimate for Julius Bär Gruppe higher to CHF 69.41 from CHF 68.18, citing a series of increased price targets in the CHF 59 to CHF 78 range and updated assumptions that pair slightly softer revenue growth with a modestly higher profit margin outlook and an essentially unchanged forward P/E of about 14x. Analyst Commentary Recent research updates on Julius Bär Gruppe show a mix of constructive and cautious views, with several firms adjusting price targets within a relatively tight band and making rating changes around specific execution risks.
SUN
CHF 153.50
Sulzer
7D
3.5%
1Y
-3.7%
Narrative Update • Jun 02

SUN: Stable Assumptions And Margins Will Support Future Upside

Analysts have kept their CHF 220.00 price target for Sulzer unchanged, pointing to relatively stable fair value assumptions along with slight adjustments to the discount rate, revenue growth, profit margin and future P/E inputs. What's in the News No recent company specific news items were provided in the available sources, so there are currently no discrete events to highlight for Sulzer.
KNIN
CHF 191.85
Kuehne + Nagel International
7D
6.4%
1Y
2.3%
Narrative Update • Jun 01

KNIN: Dividend Support And Recent Rating Upgrade Will Drive Re Rating

Narrative Update The analyst price target for Kuehne + Nagel International has been lifted modestly, with several recent CHF-based target increases. These include moves to CHF 183, CHF 170 and CHF 155, as analysts balance upgraded ratings with some downgrades and refreshed views on discount rate, revenue growth, profit margin and future P/E assumptions.
LONN
CHF 485.60
Lonza Group
7D
-3.0%
1Y
-15.3%
CFR
CHF 164.65
Compagnie Financière Richemont
7D
-2.5%
1Y
8.6%
BEAN
CHF 902.50
BELIMO Holding
7D
9.1%
1Y
12.8%
Narrative Update • May 25

BEAN: Data Center Cooling Upside Will Support Premium Future P E

Analysts kept the fair value for BELIMO Holding steady at CHF 1,060, with only modest tweaks to growth and margin assumptions. Recent Street research highlights both the perceived quality of its data center liquid cooling opportunity and some caution around tariff driven earnings pressure.
AMRZ
CHF 42.71
Amrize
7D
1.4%
1Y
n/a